SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction

Inclusion Criteria: * 18-65 years of age at the time of study entry * Diagnosed with Long COVID * Individuals of child-bearing potential must have a negative serum pregnancy test at screening and agree to on-site urine pregnancy testing at all subsequent study visits * A urine drug screen performed at the Screening Visit must be negative for drugs of abuse such as methamphetamine, cocaine, phencyclidine (PCP), and non-disclosed amphetamines and opioids/opiates. * Those with mild to moderate depression should be clinically stable for three months, without risk of suicidal ideation or behavior. Exclusion Criteria: * Breastfeeding, pregnant, or planning to become pregnant during the next six months. * In the opinion of the Investigator, any clinically significant, uncontrolled, or unstable medical or surgical condition that could affect the individual's ability to participate in the study or potentially compromise their well-being while enrolled in the study. * In the opinion of the Investigator or based on results of the HADS, evidence of a clinically significant psychiatric disorder, e.g., severe, unstable or poorly controlled depression, anxiety or obsessive-compulsive disorder; moderate or severe alcohol use disorder; substance use disorder other than mild cannabis use disorder; or any history of bipolar disorder, schizophrenia, schizoaffective disorder or other psychotic disorder. * Currently meeting criteria for ME/CFS at the pre-screening or screening visit, or a prior…